Amrita Banerjee

ORCID: 0000-0003-3631-9390

Pharmacology, Toxicology and PharmaceuticsMaterials ScienceEnvironmental ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Treatment of insulin resistance in obesity-associated type 2 diabetes mellitus through adiponectin gene therapy”.

Treatment of insulin resistance in obesity-associated type 2 diabetes mellitus through adiponectin gene therapy

International Journal of Pharmaceutics(2020)10.1016/j.ijpharm.2020.119357

N/A

0DataRank · unranked

50 citations

Divya Sharma, Riddhi Trivedi, Jagdish Singh, Amrita Banerjee

In Vitro and in Vivo Optimization of Phase Sensitive Smart Polymer for Controlled Delivery of Rivastigmine for Treatment of Alzheimer’s Disease

Pharmaceutical Research(2020)10.1007/s11095-020-2757-6

N/A

0DataRank · unranked

20 citations

Divya Sharma, Amrita Banerjee, Jagdish Singh, Lindsey Lipp

Pathobiont-triggered induction of epithelial IDO1 drives regional susceptibility to Inflammatory Bowel Disease

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.04.630951

N/A

0DataRank · unranked

0 citations

Jiawei Wang, Erin P. Smith, Luisella Spiga, Alan J. Simmons, Tae Woo Kim +27 more